510(k) Report

510(k) · Cleared

Cleared

AeroNOx 2.0 Nitric Oxide Titration & Monitoring System

K193481510(k) SpecialCleared Mar 10, 202084-day reviewClass II21 CFR 868.5165

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

International Biomedical · MRN Apparatus, Nitric Oxide Delivery

Cleared on Mar 10, 2020 as substantially equivalent to K093260 (International Biomedical, Ltd., 2009) after an 84-day review. Its family tree reaches back 2 generations to 2000.

Decided
Mar 10, 2020
Review
84 days
Class
Class II
Product code
MRN
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K000653 (2000). No later device cites it as a predicate yet.

  1. Root · 2 generations backK000653 Aeronox Universal, Model P/N 360000, Aeronox Bedside, Model P/N…Pulmonox Medical Corp. · 2000
  2. 1 generation backK093260 Aeronox Nitric Oxide Titration & Monitoring SystemInternational Biomedical, Ltd. · 2009
  3. This deviceK193481 AeroNOx 2.0 Nitric Oxide Titration & Monitoring SystemInternational Biomedical · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K000653Aeronox Universal, Model P/N 360000, Aeronox Bedside, Model P/N 360001…Pulmonox Medical Corp.2000—
−1K093260Aeronox Nitric Oxide Titration & Monitoring SystemInternational Biomedical, Ltd.2009—
0 (this device)K193481AeroNOx 2.0 Nitric Oxide Titration & Monitoring SystemInternational Biomedical2020—
FIG. 1 — Lineage of K193481, 2000–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MRN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MRN device

  1. #1 K242374 ULSPIRA TS™ Nitric Oxide Therapy Systemscore 12.6 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K093260Aeronox Nitric Oxide Titration & Monitoring System
Summary page 4
…s: II Regulation: 868.5165 Product Code: MRN Panel: Anesthesiology Predicate Device: AeroNOx 2.0 Nitric Oxide Titration & Monitoring System (K093260) Device Description: The AeroNOx 2.0 nitric oxide delivery system is specifically designed for the transmission an…
International Biomedical, Ltd.2009—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 3 companies; a new generation was cleared every 10.2 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All MRN devices

MRN Apparatus, Nitric Oxide Delivery: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · MRN

2in 2025

2007: 22008: 22009: 12010: 22011: 22012: 32013: 22015: 12018: 12020: 32022: 12023: 42024: 22025: 2
2007high 4 (2023) · low 0 (2014)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MRN

566in 2023

2012: 117 days median2020: 84 days median2023: 566 days median
2007high 566 (2023) · low 84 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MRN

2in 2025

2010: 22014: 12023: 12025: 2, 2 Class I2026 (partial year): 2
2007high 2 (2010) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · MRN

155in 2025

2007: 32008: 92009: 102010: 1552011: 552012: 242013: 322014: 792015: 1562016: 942017: 1062018: 1382019: 1442020: 1992021: 2212022: 1152023: 992024: 1382025: 155
2007high 221 (2021) · low 3 (2007)2025

MAUDE reports naming product code MRN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—03
20082—09
20091—010
20102—2155
20112—055
20123117024
20132—032
20140—179
20151—0156
20160—094
20170—0106
20181—0138
20190—0144
20203840199
20210—0221
20221—0115
20234566199
20242—0138
20252—2 (2)155
20260—2—

What is it indicated for?

The AeroNOx 2.0 is intended to provide a constant controlled concentration of nitric oxide in breathing gas by delivering a constant controlled flow of nitric oxide into the inspiratory limb of a mechanical ventilator that operates using a continuous constant flow of fresh gas into the inspiratory limb of the ventilator. The AeroNOx 2.0 is also intended to be used with a flow inflating manual ventilator (an AeroNOx 2.0 accessory), by introducing…

Read the full statement (123 words)

The AeroNOx 2.0 is intended to provide a constant controlled concentration of nitric oxide in breathing gas by delivering a constant controlled flow of nitric oxide into the inspiratory limb of a mechanical ventilator that operates using a continuous constant flow of fresh gas into the inspiratory limb of the ventilator. The AeroNOx 2.0 is also intended to be used with a flow inflating manual ventilator (an AeroNOx 2.0 accessory), by introducing controlled flows of nitric oxide into the fresh gas flow to the manual ventilator. It is also intended to monitor nitric oxide, nitrogen dioxide, and oxygen concentrations in the breathing gas.

The AeroNOx 2.0 is intended to be used within a hospital or during air or ground transport outside the hospital.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K193481: AeroNOx 2.0 Nitric Oxide Titration & Monitoring System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K193481

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026